The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Thursday, August 24, 2017
Boehringer Ingelheim has initiated a European and North American Phase IIa trial in NASH with BI 1467335 (formerly known as PXS-4728A), acquired from ...
read more
Grid Therapeutics announced the execution of an exclusive license agreement with Duke University to develop the first human derived antibody as a ...
read more
BioLineRx announced the filing of regulatory submissions required to commence a randomized, controlled Phase 3 registrational trial of BL-8040.
read more
Medivir announced the first patient has been enrolled in the company's phase I/II study of birinapant in combination with the anti-PD-1 therapy ...
read more
AstraZeneca and Merck announced that the FDA has granted approval for the PARP inhibitor, LYNPARZA.
read more
Protalex announced the FDA Office of Orphan Products Development has awarded the company a grant to support future clinical development activity of ...
read more
Thursday, August 17, 2017
Johnson & Johnson announced a new partnership with the IMTECH, part of the CSIR, to help accelerate the discovery of new treatments for tuberculosis.
read more
Wednesday, August 16, 2017
Trovagene announced positive data from a preclinical in-vivo study examining the combination of their PLK1 inhibitor, PCM-075, with a leading ...
read more
Wednesday, August 16, 2017
Spotlight Innovation announced the company has entered into a Sponsored Research Agreement with Indiana University aimed at developing treatments for ...
read more
Metacrine has entered a collaboration with Novo Nordisk A/S to develop FGF1 variants for glucose lowering and insulin sensitization.
read more
Lexicon announced additional positive data from the pivotal Phase 3 inTandem2 study of sotagliflozin, an investigational dual SGLT1 and SGLT2 ...
read more
Wednesday, August 09, 2017
PharmaMar announced the start of a multicenter quadruple combination clinical study with Aplidin, along with other compounds for the treatment of ...
read more
Wednesday, August 09, 2017
Ocugen announced the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for OCU300 (brimonidine tartrate) for the treatment ...
read more
Mitsubishi Tanabe Pharma America announced RADICAVA (edaravone), an IV therapy indicated for all adult patients diagnosed with ALS is now available ...
read more
MilliporeSigma has formed a strategic alliance with Baylor College of Medicine for Vaccine Development to advance vaccine research and development for...
read more